Sanofi India promoter group shifts 15.20% stake via block deal
- Hoechst GmbH transferred 3.5 million shares to Sanofi Healthcare India Pvt Ltd
- Stake shift represents 15.20% of total equity capital via block deal
- Total promoter group holding remains unchanged at 60.40%
- Acquisition price set at ₹3,052 per share, below VWAP benchmark cap

*this image is generated using AI for illustrative purposes only.
Sanofi India Limited witnessed a significant internal restructuring as promoter Hoechst GmbH transferred 3.5 million equity shares to Sanofi Healthcare India Private Limited on September 24, 2026.
The transaction, executed through a block deal mechanism on the National Stock Exchange of India Limited, represents an inter-se transfer within the promoter group. The acquirer is exempt from making an open offer pursuant to Regulation 10(1)(a)(iii) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Transaction Details
The transfer involved 3,500,000 equity shares, constituting 15.20% of the company's total share capital. Hoechst GmbH’s direct stake decreased from 60.38% to 45.18%, while Sanofi Healthcare India Private Limited moved from nil holdings to a 15.20% stake.
The volume-weighted average market price of Sanofi India shares over the 60 trading days preceding the notice issuance was ₹3,228.06 per share. The acquirer confirmed that the acquisition price would not exceed 25% above this computed benchmark. The disclosed value of the transaction was ₹10,68,20,00,000, excluding taxes and brokerage charges. Regulatory filings further specified the actual acquisition price at ₹3,052 per share.
| Entity | Pre-Transaction Shares | Pre-Transaction % | Post-Transaction Shares | Post-Transaction % |
|---|---|---|---|---|
| Hoechst GmbH | 13,904,722 | 60.38% | 10,404,722 | 45.18% |
| Sanofi Healthcare India Pvt Ltd | Nil | Nil | 3,500,000 | 15.20% |
| Other Promoter Group Entities | 4,865 | 0.02% | 4,865 | 0.02% |
| Total Promoter Group | 13,909,587 | 60.40% | 13,909,587 | 60.40% |
Regulatory Disclosures
Sanofi Healthcare India Private Limited submitted a Form B disclosure on September 25, 2026, detailing the purchase of equity shares from Hoechst GmbH. Prior intimation under Regulation 10(5) of the SAST Regulations was submitted to the stock exchanges on September 17, 2026, within the specified timeline.
The company subsequently filed disclosures under Regulation 7(2)(b) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, on September 28, 2026. This filing confirms the mode of acquisition as an inter-se transfer among members of the promoter and promoter group, relying on the exemption provided under Regulation 10(1)(a)(iii).
What the Numbers Show
The restructuring consolidates promoter holdings through a significant shift in ownership structure without altering the total promoter group shareholding. While Hoechst GmbH’s direct stake drops by 15.20 percentage points, the aggregate promoter and promoter group holding remains unchanged at 60.40%.
This internal realignment changes the specific entities controlling the voting rights but maintains the overall control structure. The transfer was disclosed under Regulation 29(2) of the SAST Regulations, confirming the transaction mode as an inter-se transfer among members of the promoter and promoter group.
Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE058A01010/25722636-abb9-4d29-9086-d8520eaa78b1.pdf
Historical Stock Returns for Sanofi
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.43% | -3.44% | -5.52% | -15.32% | -37.78% | 0.0% |
How might this internal restructuring influence Sanofi's long-term strategic decisions regarding local manufacturing or R&D investments in India?
Will the shift of voting rights to a local Indian entity alter Sanofi India's corporate governance practices or board composition in future AGMs?
Could this consolidation of promoter holdings through a local entity facilitate easier regulatory approvals for future product launches or acquisitions?


































